Device Recall Beckman Coulter HbA1c APT 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Beckman Coulter Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    58168
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-2170-2011
  • 사례 시작날짜
    2011-03-01
  • 사례 출판 날짜
    2011-05-10
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2012-06-28
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Assay, glycoslylated hemoglobin - Product Code LCP
  • 원인
    The recall was initiated because beckman coulter has identified a problem with two lots of hba1c apt reagent osr61177. when hba1c apt reagent lots 9390 and 9472 are calibrated with hba1c calibrator odr3032, elevated recovery may be observed for patient samples. falsely elevated hba1c values may be interpreted as increased risk for diabetes or poorly controlled diabetes. consequent medical acti.
  • 조치
    Beckman Coulter initiated the recall communication with a Product Corrective Action (PCA) letter with attached recall response form on March 1, 2011 to the affected customers. The letter explained the problem and identified the action to be taken. The PCA also instructed the consignees to: (1) Please discontinue the use of lots 9390 and 9472 and discard according to your local procedures. (2) Please contact your local Beckman Coulter support Organization for replacement reagent. (3) You may need to re-evaluate samples for HbA1c which were tested with either of the listed lots of reagent. In addition, customers were instructed to: (1) share the information with their laboratory staff and retain this notification as part of their Quality System documentation. If any of the affected product was forwarded to another laboratory, a copy of the letter should be provided to them. (2) complete and return the enclosed response form within 10 days so that the firm was assured the customer received the important communication. For any questions regarding this notice, customers were instructed to contact Customer Technical Support at 1-800-854-3633 in the U.S.A and at 00353656831111 in Europe.

Device

  • 모델명 / 제조번호(시리얼번호)
    Lot Numbers: 9390 & 9472
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    No
  • 유통
    Worldwide Distribution - USA (Nationwide) Austria, Croatia, France, Germany, Korea, Philippines, Russian Federation, Thailand, Venezuela, and Vietnam.
  • 제품 설명
    Beckman Coulter HbA1c APT (Hemoglobin A1c, Whole Blood Application), Part Number: OSR61177, Lot Numbers: 9390 & 9472 || Immuno-inhibition test for the quantitative determination of HbA1c (Hemoglobin A1c), in human whole blood, on the Beckman Coulter AU680 with whole blood automated pretreatment (APT) capability only. For in vitro diagnostic use only. The absolute HbA1c and Total Hemoglobin (THb) values generated as part of the HbA1c assay are intended for use in the calculation of the HbA1c/Total Hemoglobin ratio, and must not be used individually for diagnostic purposes.
  • Manufacturer

Manufacturer

  • 제조사 주소
    Beckman Coulter Inc., 200 S Kraemer Blvd, Brea CA 92821-6208
  • 제조사 모회사 (2017)
  • Source
    USFDA